Browsing Tag
Pascal Soriot
19 posts
AstraZeneca reports steady growth in 9M and Q3 2023 with core EPS increase
AstraZeneca has announced its financial results for the nine months (9M) and third quarter (Q3) of 2023, displaying…
AstraZeneca to establish $360m API manufacturing facility in Ireland
AstraZeneca said that it will invest $360 million in Ireland for setting up an active pharmaceutical ingredient (API)…
AstraZeneca shareholders approve $39bn acquisition of Alexion
AstraZeneca has secured its shareholders’ approval for its previously announced $39 billion acquisition of US biopharma company Alexion…
Covid antibody candidate AZD7442 : AstraZeneca, US strike deal for additional doses
AstraZeneca has agreed to supply the US government with up to half a million additional doses of AZD7442,…
AstraZeneca signs $39bn deal to acquire Alexion Pharmaceuticals
In a landmark move that’s poised to shake up the world of immunology and rare disease treatments, AstraZeneca…
AstraZeneca resumes AZD1222 Covid-19 vaccine trials after safety review
AstraZeneca has announced the resumption of its clinical trials for the AZD1222 Covid-19 vaccine candidate in multiple countries,…
AstraZeneca’s AZD7442 to enter Phase 3 clinical trials for Covid-19 prevention and treatment
AstraZeneca has announced the progression of its monoclonal antibody combination, AZD7442, into two pivotal Phase 3 clinical trials.…
AstraZeneca finalizes AZD1222 Covid-19 vaccine candidate deal with EC
AstraZeneca said that it has finalized a deal with the European Commission (EC) for the delivery of up…
AstraZeneca strikes $6bn worth deal for Daiichi Sankyo’s DS-1062
AstraZeneca has signed a deal potentially worth up to $6 billion with Daiichi Sankyo for the global development…